The influence of transdermal hormone therapy on thromboembolic risk of women at menopausal period

Tomasz Pertyński; Grzegorz Stachowiak; Tomasz Stetkiewicz; Urszula Faflik

eISSN: 2299-0038
ISSN: 1643-8876

Menopause Review/Przegląd Menopauzalny

Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

2/2006
vol. 5

Send email

Copy url:

abstract:

The influence of transdermal hormone therapy on thromboembolic risk of women at menopausal period

Tomasz Pertyński

,

Grzegorz Stachowiak

,

Tomasz Stetkiewicz

,

Urszula Faflik

Prz Menopauz 2006; 2: 92–95

Online publish date: 2006/05/12

View full text Get citation

The present article is a short review of up-to-date reports on the influence of hormone therapy (HT) on the hemostatic elements responsible for thromboembolic complications, being one of the most threatening side effect of HT administration in women at menopausal period. Transdermal HT, in a far less degree than the oral type of this therapy does it, modifies (=increases) the vascular risk of thromboembolic events. Hence it should be a therapy of the first choice for women at increased risk of thromboembolic complications in circulatory system.

keywords:

The influence of transdermal hormone therapy on thromboembolic risk of women at menopausal period

Tomasz Pertyński , Grzegorz Stachowiak , Tomasz Stetkiewicz , Urszula Faflik

thromboembolic risk, transdermal hormone therapy, coagulation, fibrinolysis, menopause

Tomasz Pertyński

,

Grzegorz Stachowiak

,

Tomasz Stetkiewicz

,

Urszula Faflik